Trial intelligence / Profile preview

Povidone Iodine 5% Eye Wash for EKC

NCT04169919Completed

Sponsor
Minia University
Start
Nov 2014
Primary completion
Oct 2018
Modality
Small Molecules
01

Overview

Open-label trial of povidone-iodine in epidemic keratoconjunctivitis (EKC) (2 arms), sponsored by Minia University. Primary endpoints: Ocular symptoms of epidemic keratoconjunctivitis at 2 weeks and Ocular signs of epidemic keratoconjunctivitis at 2 weeks. Started Nov 2014; status: completed.

02

Drugs

povidone-iodine
03

Conditions

epidemic keratoconjunctivitis (EKC)

Beyond the preview

Go deeper on NCT04169919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04169919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call